Furthermore, treatment with alpha-lipoic acid and metformin has been shown to improve insulin resistance and cognitive deficits by modulating TLR2 signaling, further supporting the involvement of TLR2-driven inflammation in metabolic dysfunctions and their neurological consequences [48]. This evidence concerns the gene TLR2 and Insulin resistance.